IRIS UniCatt

Bosello, Silvia Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.756
AS - Asia 4.638
EU - Europa 4.209
SA - Sud America 812
AF - Africa 120
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 9
Totale 15.565
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.568
SG - Singapore 2.145
CN - Cina 1.157
DE - Germania 1.143
IT - Italia 832
BR - Brasile 680
SE - Svezia 530
FR - Francia 482
VN - Vietnam 337
UA - Ucraina 243
IN - India 219
GB - Regno Unito 200
IE - Irlanda 182
FI - Finlandia 152
ID - Indonesia 145
PL - Polonia 115
JP - Giappone 100
CA - Canada 98
RU - Federazione Russa 95
HK - Hong Kong 86
BD - Bangladesh 78
TR - Turchia 76
KR - Corea 58
AR - Argentina 51
MX - Messico 50
IQ - Iraq 46
BE - Belgio 43
ZA - Sudafrica 35
NL - Olanda 34
PK - Pakistan 31
AT - Austria 30
ES - Italia 29
IR - Iran 22
MA - Marocco 22
SA - Arabia Saudita 21
VE - Venezuela 21
UZ - Uzbekistan 19
AU - Australia 18
CO - Colombia 17
EC - Ecuador 15
LT - Lituania 15
CI - Costa d'Avorio 13
JO - Giordania 13
AE - Emirati Arabi Uniti 12
KE - Kenya 12
TN - Tunisia 11
CZ - Repubblica Ceca 10
PT - Portogallo 10
RO - Romania 10
CL - Cile 9
PH - Filippine 9
AZ - Azerbaigian 8
JM - Giamaica 8
MY - Malesia 8
CR - Costa Rica 7
CH - Svizzera 6
DK - Danimarca 6
EG - Egitto 6
EU - Europa 6
IL - Israele 6
PE - Perù 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
BG - Bulgaria 5
HN - Honduras 5
HU - Ungheria 5
KG - Kirghizistan 5
UY - Uruguay 5
AL - Albania 4
ET - Etiopia 4
GR - Grecia 4
KW - Kuwait 4
NG - Nigeria 4
NP - Nepal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
CG - Congo 3
DZ - Algeria 3
LB - Libano 3
MD - Moldavia 3
NO - Norvegia 3
PA - Panama 3
PY - Paraguay 3
RS - Serbia 3
TH - Thailandia 3
BB - Barbados 2
BY - Bielorussia 2
EE - Estonia 2
GE - Georgia 2
GT - Guatemala 2
KH - Cambogia 2
LV - Lettonia 2
NI - Nicaragua 2
OM - Oman 2
SI - Slovenia 2
TJ - Tagikistan 2
VA - Santa Sede (Città del Vaticano) 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
Totale 15.537
Salva come PNG Salva come JPEG
Città #
Singapore 1.238
Ashburn 642
San Jose 641
Chandler 591
Rome 203
Beijing 188
Dublin 181
Ann Arbor 173
Hefei 169
New York 166
Los Angeles 140
Jacksonville 134
Jakarta 129
Dearborn 121
Ho Chi Minh City 119
Lauterbourg 119
The Dalles 108
Munich 107
Milan 100
San Mateo 96
Tokyo 93
Houston 89
Wilmington 88
Nanjing 84
Woodbridge 84
Helsinki 80
Hanoi 79
Frankfurt am Main 78
Seattle 76
Hong Kong 73
Dallas 67
Boston 66
Kraków 64
São Paulo 62
Fairfield 61
Moscow 59
Seoul 56
Kent 53
Santa Clara 52
Chicago 50
Nürnberg 48
Buffalo 46
Marseille 43
Brussels 42
Lawrence 42
Izmir 40
Nuremberg 40
Paris 39
Boardman 38
Cattolica 37
Bremen 34
Brooklyn 34
Nanchang 34
Orem 33
Warsaw 33
Pune 32
Atlanta 29
Düsseldorf 29
Redwood City 28
Montreal 27
Chennai 26
Guangzhou 25
London 25
Princeton 25
Shanghai 25
St Louis 25
Hebei 23
Johannesburg 23
Norwalk 23
Tianjin 23
Toronto 22
Kunming 21
Rio de Janeiro 21
Hyderabad 20
Phoenix 20
Stockholm 20
Baghdad 19
Da Nang 19
San Francisco 19
Lancaster 18
Mexico City 18
Belo Horizonte 17
Denver 17
Manchester 17
Tashkent 17
Augusta 16
Leawood 16
North Bergen 16
Trieste 16
Turku 16
Cambridge 15
Falls Church 15
Florence 15
Fremont 15
Detroit 14
Hangzhou 14
Philadelphia 14
Abidjan 13
Amman 13
Andover 13
Totale 8.256
Salva come PNG Salva come JPEG
Nome #
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 360
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 329
B CELL DEPLETION IN DIFFUSE PROGRESSIVE SYSTEMIC SCLEROSIS: SAFETY, SKIN SCORE MODIFICATION AND IL-6 MODULATION IN AN UP TO THIRTY-SIX MONTHS FOLLOW-UP OPEN-LABEL TRIAL 319
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 267
Impatto dell’inquinamento ambientale da benzene e PM10 sulla progressione clinica della sclerosi sistemica: un’analisi di correlazione. 248
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 237
MR imaging of atlantoaxial joint in early rheumatoid arthritis. 230
Atlantoepistrophic magnetic resonance imaging involvement in early rheumatoid arthritis: an aggressive tight control therapy not fully arresting the disease 211
beta-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up 211
Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease. 199
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression 198
null 198
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 196
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 187
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 184
Adult-onset Still's disease following COVID-19 vaccination 184
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 182
B CELLS IN SYSTEMIC SCLEROSIS: A POSSIBLE TARGET FOR THERAPY 174
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 171
Proteome analysis of biological fluids from autoimmune-rheumatological disorders 168
Detection of bone erosions in early rheumatoid arthritis: 3D ultrasonography versus computed tomography 168
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 168
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 166
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 166
Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels 164
Sarilumab use in severe SARS-CoV-2 pneumonia 164
ENVIRONMENTAL POLLUTION AND SYSTEMIC SCLEROSIS: A PILOT STUDY ON BENZENE AND PARTICULATE EXPOSURE AS RISK FACTORS FOR THE SYSTEMIC MANIFESTATIONS 163
Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: A 12-month followup study 161
(AS) TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis. 158
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 157
A Comprehensive Natural Language Processing Pipeline for the Chronic Lupus Disease 155
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 148
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 148
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 147
Environmental pollution and systemic sclerosis manifestations: a pilot study on benzene and particulate exposure 143
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 143
Extension of Lung Damage at Chest Computed Tomography in Severely Ill COVID-19 Patients Treated with Interleukin-6 Receptor Blockers Correlates with Inflammatory Cytokines Production and Prognosis 141
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 140
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 140
Improved Endothelial Function After Endothelin Receptor Blockade in Patients With Systemic Sclerosis 139
Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients 137
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 134
Thymosin β4 and β10 in Sjögren's syndrome: Saliva proteomics and minor salivary glands expression 134
Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study 133
Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst 132
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 129
Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status 129
Rituximab retention rate in systemic sclerosis: a long term real-life multicentre study 127
Treatment strategy introducing immunosuppressive drugs with glucocorticoids ab initio or very early in giant cell arteritis: A multicenter retrospective controlled study 126
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 122
An unusual lung involvement in scleroderma: lipoid pneumonia 122
Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung disease 121
Adult Onset Still's Disease and Radiotherapy treatment for breast cancer: Case report about management of this rare association and literature review 120
null 118
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 117
Concordance and Prognostic Relevance of Different Definitions of Systemic Sclerosis Interstitial Lung Disease Progression 116
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression 115
Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: Checklists for Clinical Practice 114
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 114
The human salivary proteome: a critical overview of the results obtained by different proteomic platforms 113
Extension of Lung Damage at Chest Computed Tomography in Severely Ill COVID-19 Patients Treated with Interleukin-6 Receptor Blockers Correlates with Inflammatory Cytokines Production and Prognosis 111
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 110
Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life 110
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus 109
Computer-aided quantification of interstitial lung disease from high resolution computed tomography images in systemic sclerosis: correlation with visual reader-based score and physiologic tests 109
Microvascular heart involvement in systemic autoimmune diseases: The purinergic pathway and therapeutic insights from the biology of the diseases 108
Sudden winter iloprost withdrawal in scleroderma patients during COVID-19 pandemic 107
Risk of burnout and stress in physicians working in a COVID team: A longitudinal survey 107
Multidisciplinary Evaluation of Interstitial Lung Diseases: New Opportunities Linked to Rheumatologist Involvement 106
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 105
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 103
Troponin in Stable Ischemic Heart Disease and Diabetes 103
Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients 102
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 102
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 102
Sixth-month remission as a predictor for twelve-month remission in polymyalgia rheumatica 101
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 98
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 97
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 95
Subclinical atherosclerosis and endothelial dysfunction in patients with polymyalgia rheumatica: a pilot study 95
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 94
Troponin in Stable Ischemic Heart Disease and Diabetes 94
Sixth-month remission as a predictor for twelve-month remission in polymyalgia rheumatica 93
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case-control study from the Italian national multicenter "SPRING" (Systemic Sclerosis Progression InvestiGation) Registry 91
FUNZIONE CARDIORESPIRATORIA, ARTERIAL STIFFNESS E LIVELLI DI NT-PRO BNP IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE ALL’ESORDIO 90
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus 87
Ecografia delle spalle in pazienti con PR: valore diagnostico ma non predittivo 86
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 84
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 84
Understanding Attitudes Toward Zoster Vaccination in the Hospital Setting: A Multidisciplinary Model to Contrast Vaccine Hesitancy in Fragile Patients—A Prospective Longitudinal Observational Study 82
Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients 80
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 79
Residual minimal disease activity in rheumatoid arthritis: a simple definition through an in-depth statistical analysis of the major outcome 78
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 78
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 77
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 77
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 77
What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19? 77
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 75
Synovial B cells of rheumatoid arthritis express ZAP-70 which increases the survival and correlates with the inflammatory and autoimmune phenotype 74
Totale 13.742
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.878
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.878
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022800 54 38 23 56 61 44 36 102 39 86 106 155
2022/20231.685 214 235 127 271 83 191 83 138 152 14 56 121
2023/20241.067 36 278 53 57 38 146 73 76 21 31 149 109
2024/20252.587 49 51 218 85 255 114 111 108 355 271 550 420
2025/20266.451 898 211 390 725 1.248 372 1.112 330 366 397 211 191
2026/2027212 212 0 0 0 0 0 0 0 0 0 0 0
Totale 15.790